Feed NRXP
NR

NRx Pharmaceuticals, Inc. NRXP · NASDAQ

$2.60 -4.06% (-$0.11)

Market cap
$117.3M
Enterprise value
$91.9M
P/E
-
Forward P/E
-
PEG
-
P/S
34.6x
P/FCF
-
EV/EBITDA
-
ROIC
-1,855.5%
Gross margin
32.7%
Net margin
-691.8%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
-
Beta
2.07
Free float
86.4%

About the company

NRx Pharmaceuticals, Inc. (NRXP) is a pharmaceutical company focused on research and development of new drugs for the treatment of serious diseases. The company specializes in therapeutic approaches for diseases that currently lack effective treatments or have inadequate treatment options. NRx Pharmaceuticals emphasizes innovation and utilizes modern technologies and scientific knowledge to discover new treatment possibilities. Their drugs are aimed at potential treatments for diseases in areas such as neurology, oncology, infectious diseases, and more. The company is actively developing drugs and conducting clinical trials to confirm the effectiveness and safety of their products. NRx Pharmaceuticals aims to bring new drugs to the market that can make a significant improvement for patients with serious diseases. NRx Pharmaceuticals, Inc. (NRXP) shares may be an attractive investment opportunity for investors interested in the pharmaceutical sector and seeking an investment in a company focused on innovative therapeutic approaches for serious diseases.

Sector

Healthcare

Industry

Biotechnology

CEO

Jonathan C. Javitt

Employees

29

Headquarters

Wilmington

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.